Clinical trial
Efficacy and Safety of Neorenal Forte as Adjuvant Treatment for the Complete Elimination of Residual Fragments After Flexible Ureterorenoscopy With Laser Lithotripsy for Renal Calculi.
NCT06651294 is registered in ClinicalTrials.gov with Neopharm Bulgaria Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Neorenal Forte as Adjuvant Treatment for the Complete Elimination of Residual Fragments After Flexible Ureterorenoscopy With Laser Lithotripsy for Renal Calculi.
- Lead sponsor
- Neopharm Bulgaria Ltd.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 1, 2025
- Completion date
- November 30, 2026
- Enrollment
- 120 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.